SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value Measurements (Details) - Estimate of Fair Value Measurement - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Heart & Lung Imaging Limited
Accrued expenses and other non-current liabilities
Business combination, contingent consideration	$ 0	$ 6,242
2019 Swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other Current Assets	7,112
Deposits and Other		15,118
Level 1 | Heart & Lung Imaging Limited
Accrued expenses and other non-current liabilities
Business combination, contingent consideration	0	0
Level 1 | 2019 Swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other Current Assets	0
Deposits and Other		0
Level 2 | Heart & Lung Imaging Limited
Accrued expenses and other non-current liabilities
Business combination, contingent consideration	0	0
Level 2 | 2019 Swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other Current Assets	7,112
Deposits and Other		15,118
Level 3 | Heart & Lung Imaging Limited
Accrued expenses and other non-current liabilities
Business combination, contingent consideration	0	6,242
Level 3 | 2019 Swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other Current Assets	$ 0
Deposits and Other		$ 0